Japan Medical Association Opposes Epadel OTC Switch
This article was originally published in PharmAsia News
Executive Summary
Japan Medical Association VP Toshio Nakagawa expressed concern regarding the switch of hyperlipidemia drug Epadel to an OTC drug at a press conference in Tokyo Nov. 21, stating that patients self-medicating for lifestyle-related diseases with no symptoms would be extremely dangerous.